Patents by Inventor Honorate A. Stelmach

Honorate A. Stelmach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fluoroether compositions and methods for inhibiting their degradation in the presnce of a lewis acid
    Publication number: 20040048932
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: June 26, 2003
    Publication date: March 11, 2004
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
    Publication number: 20030130359
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: July 3, 2002
    Publication date: July 10, 2003
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffrado, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
    Patent number: 6444859
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: September 3, 2002
    Assignees: Abbott Laboratories, Central Glass Company LTD
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
    Publication number: 20020016373
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Application
    Filed: August 8, 2001
    Publication date: February 7, 2002
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
    Patent number: 6288127
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: September 11, 2001
    Assignee: Abbott Laboratories & Central Glass Co LTD
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach
  • Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
    Patent number: 5990176
    Abstract: The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
    Type: Grant
    Filed: January 27, 1997
    Date of Patent: November 23, 1999
    Assignees: Abbott Laboratories, Central Glass Company Ltd.
    Inventors: Christopher Bieniarz, Steve H. Chang, Keith R. Cromack, Shuyen L. Huang, Toshikazu Kawai, Manami Kobayashi, David Loffredo, Rajagopalan Raghavan, Earl R. Speicher, Honorate A. Stelmach